Andres Garzona-Navas (@agarzonan) 's Twitter Profile
Andres Garzona-Navas

@agarzonan

Editor in Chief of the Costarican Journal of Cardiology 🇨🇷 Research at Mayo Clinic, MN🇺🇸 Sports Cardiology, Rehab, CV Prevention 🫀 💪 (opinions my own)

ID: 728323622666801152

calendar_today05-05-2016 20:40:58

868 Tweet

1,1K Followers

1,1K Following

Ahmed Bennis (@drbennisahmed) 's Twitter Profile Photo

Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial in HFpEF and markers of ID IV FCM improved 6MWTD and was associated with fewer serious adverse events. academic.oup.com/eurheartj/adva…

Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial

in HFpEF and markers of ID IV FCM improved 6MWTD and was associated with fewer serious adverse events.

academic.oup.com/eurheartj/adva…
American Society of Echocardiography (@ase360) 's Twitter Profile Photo

We are pleased to share this #HCM poster with you all, developed with support from Bristol Myers Squibb! Use this link to download the poster, "A Practical Approach to Echocardiographic Imaging in Patients with Hypertrophic Cardiomyopathy." bit.ly/3lLHKeI

We are pleased to share this #HCM poster with you all, developed with support from <a href="/bmsnews/">Bristol Myers Squibb</a>! 

Use this link to download the poster, "A Practical Approach to Echocardiographic Imaging in Patients with Hypertrophic Cardiomyopathy." bit.ly/3lLHKeI
Ezequiel Forte (@ezeforte) 's Twitter Profile Photo

Estudio en Pool de HFpEF en estudios #SELECT, #FLOW y los #STEP HFpEF y HFpEF-DM Mikhail Kosiborod #ESCCongress2024 ➡️4 Trials ➡️> 70% IMC >30 🔥Reduce 31% el punto combinado de IC y muerte CV

Estudio en Pool de HFpEF en estudios #SELECT, #FLOW y los #STEP HFpEF y HFpEF-DM <a href="/MkosiborodMD/">Mikhail Kosiborod</a> #ESCCongress2024 
➡️4 Trials 
➡️&gt; 70% IMC &gt;30

🔥Reduce 31% el punto combinado de IC y muerte CV
NEJM (@nejm) 's Twitter Profile Photo

Original Article: Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (FINEARTS-HF) nej.md/470x4ix #ESCardio | European Society of Cardiology

Original Article: Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (FINEARTS-HF) nej.md/470x4ix 

#ESCardio | <a href="/escardio/">European Society of Cardiology</a>
C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

Screening for AF using a 14-day, patch-based continuous ECG monitor in individuals aged ≥70 years increased detection of AF by 52%, and initiation of OAC, but did not reduce hospitalization for stroke #ESCCongress

Screening for AF using a 14-day, patch-based continuous ECG monitor in individuals aged ≥70 years increased detection of AF by 52%, and initiation of OAC, but did not reduce hospitalization for stroke #ESCCongress
JACC Journals (@jaccjournals) 's Twitter Profile Photo

A single non-HDL-C >135mg/dL or LDL-C>118mg/dL at age 18-30y predicts high atherogenic lipid exposure by 40y, a strong indicator of #ASCVD risk in middle age. bit.ly/3MAEobj #JACC Don Lloyd-Jones Venk Murthy MD PhD

A single non-HDL-C &gt;135mg/dL or LDL-C&gt;118mg/dL at age 18-30y predicts high atherogenic lipid exposure by 40y, a strong indicator of #ASCVD risk in middle age. bit.ly/3MAEobj

#JACC <a href="/dmljmd/">Don Lloyd-Jones</a> <a href="/venkmurthy/">Venk Murthy MD PhD</a>
Jonathan Kim, MD, MSc, FACC (@jonathankimmd) 's Twitter Profile Photo

Thank you Medscape and American College of Cardiology to teach a little about #SCA and #SCD in athletes. Only 10 min, could've spent 2 hours! Just an overview for those interested or who take care of #athletes #sportscards medscape.com/viewarticle/sp…